EnSolve Biosystems, Inc. – Trademark Portfolio
Entity Type: 03
EnSolve Biosystems, Inc. has 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include ENSOLVE and GREASEFEAST. The portfolio includes 2 registered trademarks. Filings span 4 Nice Classification classes, led by Class 11 (Environmental Control) and Class 3 (Cosmetics & Cleaning). This trademark owner is based in Raleigh, NC.
620 Hutton St., Suite 104
Raleigh, NC 276061490
Showing of trademarks Trademarks
Trademark Classifications
EnSolve Biosystems, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Machines and machine tools; motors and engines; machine coupling and transmission components
Frequently Asked Questions
How many trademarks does EnSolve Biosystems, Inc. have?
EnSolve Biosystems, Inc. has 9 U.S. trademarks filed with the USPTO. Of these, 2 registered, 7 cancelled.
What trademark classes does EnSolve Biosystems, Inc. file in?
EnSolve Biosystems, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 11 (Environmental Control), Class 3 (Cosmetics & Cleaning), Class 7 (Machinery), Class 40 (Treatment & Processing). Class 11 covers apparatus for lighting, heating, steam generating, cooking, refrigerating, drying.
What are EnSolve Biosystems, Inc.'s most well-known trademarks?
EnSolve Biosystems, Inc.'s registered trademark portfolio includes well-known marks such as ENSOLVE and GREASEFEAST. These are among 2 currently registered trademarks in the portfolio.
What is EnSolve Biosystems, Inc.'s trademark registration success rate?
EnSolve Biosystems, Inc. has a 22% trademark registration rate, with 2 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.